New webinar
How to master both Marketing Authorization and Joint Clinical Assessment successfully?
The European Union is transforming its health technology assessment process with the introduction of the Joint Clinical Assessment (JCA) under the new HTA Regulation. This major change aims to streamline…
View webinar
Featured resources
blog
Selection of a Notified Body for Medical Device Development
In the European Union (EU) the review and approval of medical devices and in vitro diagnostic medical devices often requires…
blog
Digital Health Series – Part 1: Defining Software as a Medical Device
Recently, the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has provided updates to the guidance Software and AI…
blog
Importance of Quality Management Review for Medical Devices
If you are an innovator developing a device, it is critical to understand the purpose and innerworkings of quality management…
webinar
Ask the Experts: MHRA’s Innovative Licensing and Access Pathway (ILAP)
In its new role of an independent regulator, the UK’s MHRA regulatory agency is emerging as a flexible and welcoming…
All our resources
More resources
publication
Microbiome Testing in Europe: Navigating Analytical, Ethical and Regulatory Challenges
In recent years, human microbiome research has flourished and has drawn attention from both healthcare professionals and general consumers as…
blog
The SoHO Regulation: A Step Forward in European Health and Safety
The European Union has recently introduced a landmark regulation aimed at enhancing the safety, quality, and accessibility of substances of…
webinar
How to master both Marketing Authorization and Joint Clinical Assessment successfully?
The European Union is transforming its health technology assessment process with the introduction of the Joint Clinical Assessment (JCA) under…
blog
New policy opens China biotechnology sector
In a recent move to foster innovation and high-quality development within China’s medical sector, Ministry of Commerce and National Health…
blog
Unlocking the potential benefits of Live Biotherapeutic Products (LBPs) for the treatment of bacterial vaginosis…
Introduction Bacterial vaginosis (BV) BV is a common vaginal condition characterised by odorous grey vaginal discharge which can be really…
webinar
Ask the Experts: How to leverage regulatory interactions to de-risk Microbiome products development in the…
Microbiome science has grown over the past years with high potential to provide innovative, efficient, and targeted solutions to various…
blog
Navigating the New FDA Draft Guidance on Platform Technologies: An Overview for Life Sciences Companies
As regulatory landscapes evolve, staying ahead of new guidelines is crucial for life sciences companies. On May 29, 2024, the…
blog
De-risk Clinical Trials by Starting with Patient Insights and their Integration
Have you ever asked yourself how, as a patient, you would react if your physician proposed you to participate in…